Panel Discussion: Addressing the Biomarker Bottlenecks to Identify Areas of Progress: What is Needed?

Time: 5:30 pm
day: Day 1


  • Capitalize on this opportunity to collectively discuss and address the critical biomarker bottlenecks that Inflammasome therapeutics face
  • Alongside leading minds and industry pioneers, discuss the complexities associated with identifying and quantifying measures of inflammasomes using sophisticated biochemical techniques
  • Explore strategies for overcoming these challenges to facilitate translation into clinical practice